Selective lipoxygenase inhibitor reduces bile acid-induced gastric mucosal injury

Theodore R. Sullivan, Juan A. Cordero, David W. Mercer, Wallace P. Ritchie, Daniel T. Dempsey

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Leukotriene receptor blockade attenuates topical bile acid-induced gastric mucosal injury, suggesting that peptidyl-leukotrienes may be mediators of this injury. The purpose of this study was to test the hypothesis that a selective 5-lipoxygenase inhibitor protects against bile acid-induced gastric epithelial injury in the rat. Prior to injury with 10 and 20 mM acidified taurocholate (pH 1.2), rat stomachs were pretreated with either vehicle or WY50295K (selective 5-lipoxygenase inhibitor, 20 mg/kg). Injury was assessed by measuring net transmucosal hydrogen ion flux, luminal appearance of DNA, and gross mucosal injury. Topical 5-lipoxygenase inhibitor significantly reduced luminal H+ ion loss, surface epithelial cell loss (as measured by luminal accumulation of DNA), and gross mucosal injury in bile acid-injured stomachs compared to controls. This study lends further support to the hypothesis that leukotrienes may be mediators of bile acid-induced gastric mucosal injury.

Original languageEnglish (US)
Pages (from-to)568-571
Number of pages4
JournalJournal of Surgical Research
Issue number6
StatePublished - Dec 1992
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Selective lipoxygenase inhibitor reduces bile acid-induced gastric mucosal injury'. Together they form a unique fingerprint.

Cite this